世界の炎症性腸疾患市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Inflammatory Bowel Disease Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3159 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、炎症性腸疾患のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アミノサリチル酸塩、抗生物質、コルチコステロイド、生物学的療法（生物製剤）、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・炎症性腸疾患の市場動向 ・企業の競争状況、市場シェア ・炎症性腸疾患の種類別市場規模（アミノサリチル酸塩、抗生物質、コルチコステロイド、生物学的療法（生物製剤）、その他） ・炎症性腸疾患の用途別市場規模（病院、クリニック、その他） ・炎症性腸疾患の北米市場規模2016-2027（アメリカ、カナダ） ・炎症性腸疾患のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・炎症性腸疾患のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・炎症性腸疾患の中南米市場規模2016-2027（メキシコ、ブラジル） ・炎症性腸疾患の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb Company、Baxter International、Johnson & Johnson、Sanofi-Aventis、Abbott Laboratories、Pluristem Therapeutics、Pfizer、AstraZeneca、Cephalon、Amgen） ・結論

Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn’s diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn’s disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum.
Medical treatment of IBD is individualised to each patient. The choice of which drugs to use and by which route to administer them (oral, rectal, injection, infusion) depends on factors including the type, distribution, and severity of the patient’s disease, as well as other historical and biochemical prognostic factors, and patient preferences. For example, mesalazine is more useful in ulcerative colitis than in Crohn’s disease. Generally, depending on the level of severity, IBD may require immunosuppression to control the symptoms, with drugs such as prednisone, TNF inhibitors, azathioprine (Imuran), methotrexate, or 6-mercaptopurine.

Market Analysis and Insights: Global Inflammatory Bowel Disease Market
The global Inflammatory Bowel Disease market size is projected to reach US$ 16250 million by 2026, from US$ 12720 million in 2019, at a CAGR of 3.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Inflammatory Bowel Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Inflammatory Bowel Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Inflammatory Bowel Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Inflammatory Bowel Disease market.

Global Inflammatory Bowel Disease Scope and Market Size
Inflammatory Bowel Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Inflammatory Bowel Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Aminosalicylates
Antibiotics
Corticosteroids
Biologic therapies (biological drugs)
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol-Myers Squibb Company
Baxter International
Johnson & Johnson
Sanofi-Aventis
Abbott Laboratories
Pluristem Therapeutics
Pfizer
AstraZeneca
Cephalon

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Aminosalicylates
1.2.3 Antibiotics
1.2.4 Corticosteroids
1.2.5 Biologic therapies (biological drugs)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease Market Perspective (2016-2027)
2.2 Inflammatory Bowel Disease Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Inflammatory Bowel Disease Historic Market Share by Regions (2016-2021)
2.2.3 Inflammatory Bowel Disease Forecasted Market Size by Regions (2022-2027)
2.3 Inflammatory Bowel Disease Industry Dynamic
2.3.1 Inflammatory Bowel Disease Market Trends
2.3.2 Inflammatory Bowel Disease Market Drivers
2.3.3 Inflammatory Bowel Disease Market Challenges
2.3.4 Inflammatory Bowel Disease Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease Players by Revenue
3.1.1 Global Top Inflammatory Bowel Disease Players by Revenue (2016-2021)
3.1.2 Global Inflammatory Bowel Disease Revenue Market Share by Players (2016-2021)
3.2 Global Inflammatory Bowel Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Inflammatory Bowel Disease Revenue
3.4 Global Inflammatory Bowel Disease Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Revenue in 2020
3.5 Inflammatory Bowel Disease Key Players Head office and Area Served
3.6 Key Players Inflammatory Bowel Disease Product Solution and Service
3.7 Date of Enter into Inflammatory Bowel Disease Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Inflammatory Bowel Disease Breakdown Data by Type
4.1 Global Inflammatory Bowel Disease Historic Market Size by Type (2016-2021)
4.2 Global Inflammatory Bowel Disease Forecasted Market Size by Type (2022-2027)

5 Inflammatory Bowel Disease Breakdown Data by Application
5.1 Global Inflammatory Bowel Disease Historic Market Size by Application (2016-2021)
5.2 Global Inflammatory Bowel Disease Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Inflammatory Bowel Disease Market Size (2016-2027)
6.2 North America Inflammatory Bowel Disease Market Size by Type
6.2.1 North America Inflammatory Bowel Disease Market Size by Type (2016-2021)
6.2.2 North America Inflammatory Bowel Disease Market Size by Type (2022-2027)
6.2.3 North America Inflammatory Bowel Disease Market Size by Type (2016-2027)
6.3 North America Inflammatory Bowel Disease Market Size by Application
6.3.1 North America Inflammatory Bowel Disease Market Size by Application (2016-2021)
6.3.2 North America Inflammatory Bowel Disease Market Size by Application (2022-2027)
6.3.3 North America Inflammatory Bowel Disease Market Size by Application (2016-2027)
6.4 North America Inflammatory Bowel Disease Market Size by Country
6.4.1 North America Inflammatory Bowel Disease Market Size by Country (2016-2021)
6.4.2 North America Inflammatory Bowel Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Inflammatory Bowel Disease Market Size (2016-2027)
7.2 Europe Inflammatory Bowel Disease Market Size by Type
7.2.1 Europe Inflammatory Bowel Disease Market Size by Type (2016-2021)
7.2.2 Europe Inflammatory Bowel Disease Market Size by Type (2022-2027)
7.2.3 Europe Inflammatory Bowel Disease Market Size by Type (2016-2027)
7.3 Europe Inflammatory Bowel Disease Market Size by Application
7.3.1 Europe Inflammatory Bowel Disease Market Size by Application (2016-2021)
7.3.2 Europe Inflammatory Bowel Disease Market Size by Application (2022-2027)
7.3.3 Europe Inflammatory Bowel Disease Market Size by Application (2016-2027)
7.4 Europe Inflammatory Bowel Disease Market Size by Country
7.4.1 Europe Inflammatory Bowel Disease Market Size by Country (2016-2021)
7.4.2 Europe Inflammatory Bowel Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Inflammatory Bowel Disease Market Size (2016-2027)
8.2 Asia-Pacific Inflammatory Bowel Disease Market Size by Type
8.2.1 Asia-Pacific Inflammatory Bowel Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Inflammatory Bowel Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Inflammatory Bowel Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Inflammatory Bowel Disease Market Size by Application
8.3.1 Asia-Pacific Inflammatory Bowel Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Inflammatory Bowel Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Inflammatory Bowel Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Inflammatory Bowel Disease Market Size by Region
8.4.1 Asia-Pacific Inflammatory Bowel Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Inflammatory Bowel Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Inflammatory Bowel Disease Market Size (2016-2027)
9.2 Latin America Inflammatory Bowel Disease Market Size by Type
9.2.1 Latin America Inflammatory Bowel Disease Market Size by Type (2016-2021)
9.2.2 Latin America Inflammatory Bowel Disease Market Size by Type (2022-2027)
9.2.3 Latin America Inflammatory Bowel Disease Market Size by Type (2016-2027)
9.3 Latin America Inflammatory Bowel Disease Market Size by Application
9.3.1 Latin America Inflammatory Bowel Disease Market Size by Application (2016-2021)
9.3.2 Latin America Inflammatory Bowel Disease Market Size by Application (2022-2027)
9.3.3 Latin America Inflammatory Bowel Disease Market Size by Application (2016-2027)
9.4 Latin America Inflammatory Bowel Disease Market Size by Country
9.4.1 Latin America Inflammatory Bowel Disease Market Size by Country (2016-2021)
9.4.2 Latin America Inflammatory Bowel Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Inflammatory Bowel Disease Market Size (2016-2027)
10.2 Middle East & Africa Inflammatory Bowel Disease Market Size by Type
10.2.1 Middle East & Africa Inflammatory Bowel Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Inflammatory Bowel Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Inflammatory Bowel Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Inflammatory Bowel Disease Market Size by Application
10.3.1 Middle East & Africa Inflammatory Bowel Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Inflammatory Bowel Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Inflammatory Bowel Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Inflammatory Bowel Disease Market Size by Country
10.4.1 Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol-Myers Squibb Company
11.1.1 Bristol-Myers Squibb Company Company Details
11.1.2 Bristol-Myers Squibb Company Business Overview
11.1.3 Bristol-Myers Squibb Company Inflammatory Bowel Disease Introduction
11.1.4 Bristol-Myers Squibb Company Revenue in Inflammatory Bowel Disease Business (2016-2021)
11.1.5 Bristol-Myers Squibb Company Recent Development
11.2 Baxter International
11.2.1 Baxter International Company Details
11.2.2 Baxter International Business Overview
11.2.3 Baxter International Inflammatory Bowel Disease Introduction
11.2.4 Baxter International Revenue in Inflammatory Bowel Disease Business (2016-2021)
11.2.5 Baxter International Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Inflammatory Bowel Disease Introduction
11.3.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Inflammatory Bowel Disease Introduction
11.4.4 Sanofi-Aventis Revenue in Inflammatory Bowel Disease Business (2016-2021)
11.4.5 Sanofi-Aventis Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Inflammatory Bowel Disease Introduction
11.5.4 Abbott Laboratories Revenue in Inflammatory Bowel Disease Business (2016-2021)
11.5.5 Abbott Laboratories Recent Development
11.6 Pluristem Therapeutics
11.6.1 Pluristem Therapeutics Company Details
11.6.2 Pluristem Therapeutics Business Overview
11.6.3 Pluristem Therapeutics Inflammatory Bowel Disease Introduction
11.6.4 Pluristem Therapeutics Revenue in Inflammatory Bowel Disease Business (2016-2021)
11.6.5 Pluristem Therapeutics Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Inflammatory Bowel Disease Introduction
11.7.4 Pfizer Revenue in Inflammatory Bowel Disease Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Inflammatory Bowel Disease Introduction
11.8.4 AstraZeneca Revenue in Inflammatory Bowel Disease Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Cephalon
11.9.1 Cephalon Company Details
11.9.2 Cephalon Business Overview
11.9.3 Cephalon Inflammatory Bowel Disease Introduction
11.9.4 Cephalon Revenue in Inflammatory Bowel Disease Business (2016-2021)
11.9.5 Cephalon Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Inflammatory Bowel Disease Introduction
11.10.4 Amgen Revenue in Inflammatory Bowel Disease Business (2016-2021)
11.10.5 Amgen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Inflammatory Bowel Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Aminosalicylates
Table 3. Key Players of Antibiotics
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Biologic therapies (biological drugs)
Table 6. Key Players of Others
Table 7. Global Inflammatory Bowel Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Inflammatory Bowel Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Inflammatory Bowel Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Inflammatory Bowel Disease Market Share by Regions (2016-2021)
Table 11. Global Inflammatory Bowel Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Inflammatory Bowel Disease Market Share by Regions (2022-2027)
Table 13. Inflammatory Bowel Disease Market Trends
Table 14. Inflammatory Bowel Disease Market Drivers
Table 15. Inflammatory Bowel Disease Market Challenges
Table 16. Inflammatory Bowel Disease Market Restraints
Table 17. Global Inflammatory Bowel Disease Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Inflammatory Bowel Disease Market Share by Players (2016-2021)
Table 19. Global Top Inflammatory Bowel Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease as of 2020)
Table 20. Ranking of Global Top Inflammatory Bowel Disease Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Inflammatory Bowel Disease Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Inflammatory Bowel Disease Product Solution and Service
Table 24. Date of Enter into Inflammatory Bowel Disease Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Inflammatory Bowel Disease Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Inflammatory Bowel Disease Revenue Market Share by Type (2016-2021)
Table 28. Global Inflammatory Bowel Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Inflammatory Bowel Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Inflammatory Bowel Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Inflammatory Bowel Disease Revenue Market Share by Application (2016-2021)
Table 32. Global Inflammatory Bowel Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Inflammatory Bowel Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Inflammatory Bowel Disease Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Inflammatory Bowel Disease Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Inflammatory Bowel Disease Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Inflammatory Bowel Disease Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Inflammatory Bowel Disease Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Inflammatory Bowel Disease Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Inflammatory Bowel Disease Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Inflammatory Bowel Disease Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Inflammatory Bowel Disease Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Inflammatory Bowel Disease Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Inflammatory Bowel Disease Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Inflammatory Bowel Disease Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Inflammatory Bowel Disease Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Inflammatory Bowel Disease Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Inflammatory Bowel Disease Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Inflammatory Bowel Disease Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Inflammatory Bowel Disease Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Inflammatory Bowel Disease Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Inflammatory Bowel Disease Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Inflammatory Bowel Disease Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Inflammatory Bowel Disease Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Inflammatory Bowel Disease Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Inflammatory Bowel Disease Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Inflammatory Bowel Disease Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Inflammatory Bowel Disease Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Inflammatory Bowel Disease Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Inflammatory Bowel Disease Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Inflammatory Bowel Disease Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2022-2027) & (US$ Million)
Table 64. Bristol-Myers Squibb Company Company Details
Table 65. Bristol-Myers Squibb Company Business Overview
Table 66. Bristol-Myers Squibb Company Inflammatory Bowel Disease Product
Table 67. Bristol-Myers Squibb Company Revenue in Inflammatory Bowel Disease Business (2016-2021) & (US$ Million)
Table 68. Bristol-Myers Squibb Company Recent Development
Table 69. Baxter International Company Details
Table 70. Baxter International Business Overview
Table 71. Baxter International Inflammatory Bowel Disease Product
Table 72. Baxter International Revenue in Inflammatory Bowel Disease Business (2016-2021) & (US$ Million)
Table 73. Baxter International Recent Development
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Inflammatory Bowel Disease Product
Table 77. Johnson & Johnson Revenue in Inflammatory Bowel Disease Business (2016-2021) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. Sanofi-Aventis Company Details
Table 80. Sanofi-Aventis Business Overview
Table 81. Sanofi-Aventis Inflammatory Bowel Disease Product
Table 82. Sanofi-Aventis Revenue in Inflammatory Bowel Disease Business (2016-2021) & (US$ Million)
Table 83. Sanofi-Aventis Recent Development
Table 84. Abbott Laboratories Company Details
Table 85. Abbott Laboratories Business Overview
Table 86. Abbott Laboratories Inflammatory Bowel Disease Product
Table 87. Abbott Laboratories Revenue in Inflammatory Bowel Disease Business (2016-2021) & (US$ Million)
Table 88. Abbott Laboratories Recent Development
Table 89. Pluristem Therapeutics Company Details
Table 90. Pluristem Therapeutics Business Overview
Table 91. Pluristem Therapeutics Inflammatory Bowel Disease Product
Table 92. Pluristem Therapeutics Revenue in Inflammatory Bowel Disease Business (2016-2021) & (US$ Million)
Table 93. Pluristem Therapeutics Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Inflammatory Bowel Disease Product
Table 97. Pfizer Revenue in Inflammatory Bowel Disease Business (2016-2021) & (US$ Million)
Table 98. Pfizer Recent Development
Table 99. AstraZeneca Company Details
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Revenue in Inflammatory Bowel Disease Business (2016-2021) & (US$ Million)
Table 102. AstraZeneca Recent Development
Table 103. Cephalon Company Details
Table 104. Cephalon Business Overview
Table 105. Cephalon Inflammatory Bowel Disease Product
Table 106. Cephalon Revenue in Inflammatory Bowel Disease Business (2016-2021) & (US$ Million)
Table 107. Cephalon Recent Development
Table 108. Amgen Company Details
Table 109. Amgen Business Overview
Table 110. Amgen Inflammatory Bowel Disease Product
Table 111. Amgen Revenue in Inflammatory Bowel Disease Business (2016-2021) & (US$ Million)
Table 112. Amgen Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inflammatory Bowel Disease Market Share by Type: 2020 VS 2027
Figure 2. Aminosalicylates Features
Figure 3. Antibiotics Features
Figure 4. Corticosteroids Features
Figure 5. Biologic therapies (biological drugs) Features
Figure 6. Others Features
Figure 7. Global Inflammatory Bowel Disease Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Inflammatory Bowel Disease Report Years Considered
Figure 12. Global Inflammatory Bowel Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Inflammatory Bowel Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Inflammatory Bowel Disease Market Share by Regions: 2020 VS 2027
Figure 15. Global Inflammatory Bowel Disease Market Share by Regions (2022-2027)
Figure 16. Global Inflammatory Bowel Disease Market Share by Players in 2020
Figure 17. Global Top Inflammatory Bowel Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Revenue in 2020
Figure 19. Global Inflammatory Bowel Disease Revenue Market Share by Type (2016-2021)
Figure 20. Global Inflammatory Bowel Disease Revenue Market Share by Type (2022-2027)
Figure 21. North America Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Inflammatory Bowel Disease Market Share by Type (2016-2027)
Figure 23. North America Inflammatory Bowel Disease Market Share by Application (2016-2027)
Figure 24. North America Inflammatory Bowel Disease Market Share by Country (2016-2027)
Figure 25. United States Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Inflammatory Bowel Disease Market Share by Type (2016-2027)
Figure 29. Europe Inflammatory Bowel Disease Market Share by Application (2016-2027)
Figure 30. Europe Inflammatory Bowel Disease Market Share by Country (2016-2027)
Figure 31. Germany Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Inflammatory Bowel Disease Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Inflammatory Bowel Disease Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Inflammatory Bowel Disease Market Share by Region (2016-2027)
Figure 41. China Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Inflammatory Bowel Disease Market Share by Type (2016-2027)
Figure 49. Latin America Inflammatory Bowel Disease Market Share by Application (2016-2027)
Figure 50. Latin America Inflammatory Bowel Disease Market Share by Country (2016-2027)
Figure 51. Mexico Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Inflammatory Bowel Disease Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Inflammatory Bowel Disease Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Inflammatory Bowel Disease Market Share by Country (2016-2027)
Figure 57. Turkey Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Inflammatory Bowel Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Inflammatory Bowel Disease Business (2016-2021)
Figure 61. Baxter International Revenue Growth Rate in Inflammatory Bowel Disease Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Business (2016-2021)
Figure 63. Sanofi-Aventis Revenue Growth Rate in Inflammatory Bowel Disease Business (2016-2021)
Figure 64. Abbott Laboratories Revenue Growth Rate in Inflammatory Bowel Disease Business (2016-2021)
Figure 65. Pluristem Therapeutics Revenue Growth Rate in Inflammatory Bowel Disease Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Inflammatory Bowel Disease Business (2016-2021)
Figure 68. Cephalon Revenue Growth Rate in Inflammatory Bowel Disease Business (2016-2021)
Figure 69. Amgen Revenue Growth Rate in Inflammatory Bowel Disease Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---